Viewing Study NCT05194293


Ignite Creation Date: 2025-12-25 @ 1:14 AM
Ignite Modification Date: 2025-12-25 @ 11:24 PM
Study NCT ID: NCT05194293
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2025-09-04
First Post: 2021-12-02
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: Regorafenib and Durvalumab for the Treatment of High-Risk Liver Cancer
Sponsor: Academic and Community Cancer Research United
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module